Previous 10 | Next 10 |
Intrexon Corporation ( XON ) has been on an interesting ride this year, starting the year in the $7/share range before dropping massively to $4-5/share, recovering back to the $8 range after an insider buying spree from the CEO during late spring/early summer, and now dropping again to the nea...
GHENT, Belgium , Aug. 19, 2019 /PRNewswire/ -- ActoBio Therapeutics, Inc. , a wholly owned subsidiary of Intrexon Corporation (NASDAQ: XON) and innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents, announced that the U.S. Fo...
The following slide deck was published by Intrexon Corporation in conjunction with their 2019 Q2 earnings Read more ...
Intrexon Corp (XON) Q2 2019 Earnings Conference Call August 08, 2019, 17:00 ET Company Participants Steven Harasym - VP, IR Thomas Bostick - COO Randal Kirk - Chairman & CEO Conference Call Participants Jason Butler - JMP Securities Tejas Savant - JPMorgan Chase &...
Intrexon (NASDAQ: XON ): Q2 GAAP EPS of -$0.25 beats by $0.05 . Revenue of $35.99M (-20.5% Y/Y) beats by $6.37M . Shares +3.7% AH. Press Release More news on: Intrexon Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news,
GERMANTOWN, Md. , Aug. 8, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its second quarter and first half financial results for 2019...
GERMANTOWN, Md. , Aug. 5, 2019 /PRNewswire/ -- Precigen, Inc. , a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that...
Earlier this year I discussed why I am bearish overall on Cronos Group Inc ( CRON ), but I did note the company's partnership with Ginkgo Bioworks was a key part of the bull thesis. That partnership sees Ginkgo attempting produce cannabinoids via biosynthesis using yeast, rather than by ...
GERMANTOWN, Md. , Aug. 1, 2019 /PRNewswire/ -- Intrexon Corporation (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced it will release second quarter and first half 2019 financial resu...
GHENT, Belgium, July 1, 2019 /PRNewswire/ -- ActoBio Therapeutics, Inc. , a wholly owned subsidiary of Intrexon Corporation (NASDAQ: XON) and innovative clinical-stage biotechnology company focused on a new class of microbe-based therapeutic agents, has announced that it will ...
News, Short Squeeze, Breakout and More Instantly...
Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares PR Newswire GERMANTOWN, Md. , Jan. 26, 2021 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN) announced today the closing of its previously ann...
Pioneer Natural Resources (PXD) is well positioned to benefit from the recovery of the global economy because the demand for oil and natural gas will rise with the resumption of industrial operations. Also, the company’s progress on strategic acquisitions and in providing unique scale ...
Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference - Management will also participate in a panel discussion at the H.C. Wainwright BioConnect 2021 Conference - PR Newswire GERMANTOWN, Md. , Jan. 6, 2021 /PRNewswire/ -- Precigen, In...